|Articles|June 27, 2022
Tips for Tailoring eConsent for Optimal Patient Centricity
Author(s)Medable
Over 70% of potential research participants live >2 hours away from a research site, & patient drop-out rates can reach 30% depending on the therapeutic area. The Solution: Medable eConsent Why? 1. Medable eConsent enables the enrollment of underrepresented, diverse populations through remote consenting. 2. Medable eConsent has proven to reduce screening timelines by 50%, & increase patient engagement by 15%+.
Related Content
Sponsored Content
Sponsored Content
Sponsored Content
Trending on Pharmaceutical Technology
1
What FDA's AI Warning Letter Tells Us About GMP Accountability
2
Why Are Drugmakers Racing to Acquire ADC Payload Platforms?
3
Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers
4
The Evolving World of Counterfeit Drugs...Where Does Serialization Fit?
5